Jonas Santol

523 total citations
30 papers, 152 citations indexed

About

Jonas Santol is a scholar working on Hepatology, Oncology and Epidemiology. According to data from OpenAlex, Jonas Santol has authored 30 papers receiving a total of 152 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 10 papers in Oncology and 10 papers in Epidemiology. Recurrent topics in Jonas Santol's work include Liver physiology and pathology (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Jonas Santol is often cited by papers focused on Liver physiology and pathology (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Jonas Santol collaborates with scholars based in Austria, United States and United Kingdom. Jonas Santol's co-authors include Patrick Starlinger, Ernesto Sparrelid, David Pereyra, B. Dasari, Pim B. Olthof, Joris I. Erdmann, Stefan Gilg, Alice Assinger, Hubert Hackl and Thomas Gruenberger and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Scientific Reports.

In The Last Decade

Jonas Santol

26 papers receiving 151 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonas Santol Austria 7 76 67 40 24 23 30 152
Hannah K. Jackson United Kingdom 5 39 0.5× 41 0.6× 15 0.4× 30 1.3× 15 0.7× 9 105
H. Bennani France 5 31 0.4× 58 0.9× 19 0.5× 53 2.2× 9 0.4× 14 161
Raphaella Ferreira United States 7 37 0.5× 38 0.6× 35 0.9× 15 0.6× 25 1.1× 18 114
Marcela Galoppo Argentina 8 93 1.2× 133 2.0× 28 0.7× 20 0.8× 13 0.6× 9 188
Rachel Etherington United Kingdom 5 34 0.4× 33 0.5× 33 0.8× 27 1.1× 9 0.4× 7 105
Diane R. Abraczinskas United States 6 139 1.8× 135 2.0× 99 2.5× 58 2.4× 16 0.7× 10 260
Seiji Tsunematsu Japan 6 54 0.7× 37 0.6× 20 0.5× 8 0.3× 8 0.3× 7 93
Martina Gagliardi Italy 7 42 0.6× 53 0.8× 22 0.6× 74 3.1× 31 1.3× 9 179
Makiko Koyabu Japan 5 116 1.5× 78 1.2× 100 2.5× 31 1.3× 10 0.4× 7 210

Countries citing papers authored by Jonas Santol

Since Specialization
Citations

This map shows the geographic impact of Jonas Santol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Santol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Santol more than expected).

Fields of papers citing papers by Jonas Santol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas Santol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Santol. The network helps show where Jonas Santol may publish in the future.

Co-authorship network of co-authors of Jonas Santol

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas Santol. A scholar is included among the top collaborators of Jonas Santol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas Santol. Jonas Santol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santol, Jonas, et al.. (2025). Surgical glove perforation during intramedullary nailing of intertrochanteric fractures. Scientific Reports. 15(1). 1203–1203.
2.
Santol, Jonas, Zhihao Li, Lionel Aurelien Kankeu Fonkoua, et al.. (2025). Conversion to Resection After Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Borderline Resectable CCA: A Real-World Exploratory Analysis. Annals of Surgical Oncology. 32(10). 7215–7227.
3.
Li, Zhihao, Jonas Santol, Lionel Aurelien Kankeu Fonkoua, et al.. (2025). Real-World Single-Center Experience with Neoadjuvant Gemcitabine, Cisplatin, and Durvalumab in Borderline Resectable Cholangiocarcinoma. Annals of Surgical Oncology. 32(10). 7228–7239.
4.
Santol, Jonas, David Pereyra, Brigitte Wolf, et al.. (2025). PNPLA3 polymorphism worsens chemotherapy associated liver injury and affects overall survival in colorectal cancer patients with liver metastasis undergoing hepatic resection. EBioMedicine. 120. 105928–105928. 1 indexed citations
5.
Santol, Jonas, Birgit Gruenberger, A. Lenauer, et al.. (2024). Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer: Long-Term Follow-Up of the ASSO-LM1 Trial. Cancers. 16(5). 857–857. 1 indexed citations
6.
Santol, Jonas, Dragana Rajcic, Pia Schuler, et al.. (2024). Soluble TREM2 reflects liver fibrosis status and predicts postoperative liver dysfunction after liver surgery. JHEP Reports. 7(4). 101226–101226. 2 indexed citations
7.
Hammond, Thomas, David Pereyra, Jonas Santol, et al.. (2024). HMGB1-Mediated Cell Death—A Crucial Element in Post-Hepatectomy Liver Failure. International Journal of Molecular Sciences. 25(13). 7150–7150. 3 indexed citations
8.
Gudmundsdottir, Hallbera, Hubert Hackl, Jonas Santol, et al.. (2024). Neuroendocrine Tumors of Unknown Primary in the Setting of Cytoreductive Hepatectomy. Annals of Surgical Oncology. 31(8). 4931–4941. 2 indexed citations
9.
Santol, Jonas, et al.. (2024). Close negative correlation of local and circulating Dickkopf-1 and Sclerostin levels during human fracture healing. Scientific Reports. 14(1). 6524–6524. 5 indexed citations
10.
11.
Starlinger, Patrick, David Pereyra, Jonas Santol, et al.. (2023). Transcriptomic landscapes of effective and failed liver regeneration in humans. JHEP Reports. 5(4). 100683–100683. 8 indexed citations
12.
Starlinger, Patrick, David Pereyra, Judith Stift, et al.. (2023). Tyrosine phosphorylation of YAP‐1 in biliary epithelial cells mediates posthepatectomy liver regeneration and is affected by serotonin. Journal of Cellular Biochemistry. 124(5). 687–700. 1 indexed citations
13.
14.
Schrottmaier, Waltraud C., Stefan Heber, David Pereyra, et al.. (2023). Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers. Journal of Infection and Public Health. 16(3). 384–392.
15.
Santol, Jonas, David Pereyra, Johannes Laengle, et al.. (2023). Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration. Scientific Reports. 13(1). 15980–15980. 4 indexed citations
16.
Santol, Jonas, David Pereyra, Stefanie Haegele, et al.. (2023). The Ratio of Activin A and Follistatin-Like 3 Is Associated With Posthepatectomy Liver Failure and Morbidity in Patients Undergoing Liver Resection. SHILAP Revista de lepidopterología. 2(5). 642–651. 1 indexed citations
17.
Karolyi, Mario, Erich Pawelka, Wolfgang Hoepler, et al.. (2022). Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort. Infection. 51(4). 851–858. 6 indexed citations
18.
Pereyra, David, et al.. (2021). Pathophysiology of Bile Acids Affects Liver Regeneration in Patients Undergoing Liver Resection. HPB. 23. S177–S178. 1 indexed citations
19.
Jonas, Jan Philipp, Hubert Hackl, David Pereyra, et al.. (2021). Circulating metabolites as a concept beyond tumor biology determining disease recurrence after resection of colorectal liver metastasis. HPB. 24(1). 116–129. 4 indexed citations
20.
Schrottmaier, Waltraud C., David Pereyra, Jonas Santol, et al.. (2021). Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5. Frontiers in Cardiovascular Medicine. 8. 779073–779073. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hannah K. Jackson Breakdown of academic impact, for papers by H. Bennani Breakdown of academic impact, for papers by Raphaella Ferreira Breakdown of academic impact, for papers by Marcela Galoppo Breakdown of academic impact, for papers by Rachel Etherington Breakdown of academic impact, for papers by Diane R. Abraczinskas Breakdown of academic impact, for papers by Seiji Tsunematsu Breakdown of academic impact, for papers by Martina Gagliardi Breakdown of academic impact, for papers by Makiko Koyabu
Rankless by CCL
2026